Development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the COVID-19 pandemic
Background Seven-day clinical pharmacy services in the acute sector of the National Health Service are limited. There is a paucity of evidential patient benefit. This limits investment and infrastructure, despite United Kingdom wide calls. Aim To optimise medicines seven-days a week during surge-2 o...
Gespeichert in:
| Veröffentlicht in: | International journal of clinical pharmacy 2023-04, Vol.45 (2), p.293-303 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 303 |
|---|---|
| container_issue | 2 |
| container_start_page | 293 |
| container_title | International journal of clinical pharmacy |
| container_volume | 45 |
| creator | Cheng, C. Walsh, A. Jones, S. Matthews, S. Weerasooriya, D. Fernandes, R. J. McKenzie, C. A. |
| description | Background
Seven-day clinical pharmacy services in the acute sector of the National Health Service are limited. There is a paucity of evidential patient benefit. This limits investment and infrastructure, despite United Kingdom wide calls.
Aim
To optimise medicines seven-days a week during surge-2 of the COVID-19 pandemic through implementation of a seven-day clinical pharmacy service. This paper describes service development, evaluation and sustainability.
Setting
A tertiary-referral teaching hospital, London, United Kingdom.
Development
The seven-day clinical pharmacy service was developed to critical care, acute and general medical patients. Clinical leads developed the service specification and defined priorities, targeting complex patients and transfer of care. Contributing staff were briefed and training materials developed.
Implementation
The service was implemented in January 2021 for 11 weeks. Multidisciplinary team communication brought challenges; strategies were employed to overcome these.
Evaluation
A prospective observational study was conducted in intervention wards over two weekends in February 2021. 1584 beds were occupied and 602 patients included. 346 interventions were reported and rated; 85.6% had high or moderate impact; 56.7% were time-critical.
The proportion of medicines reconciliation within 24-h of admission was analysed across the hospital between November 2020 and May 2021. During implementation, patients admitted Friday-Sunday were more likely to receive medicines reconciliation within 24-h (RR 1.41 (95% CI 1.34–1.47),
p
|
| doi_str_mv | 10.1007/s11096-022-01475-8 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9650667</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A747439086</galeid><sourcerecordid>A747439086</sourcerecordid><originalsourceid>FETCH-LOGICAL-c541t-c21645a9576d34266041372b2a757f3f22ba04240b35efba1737d58ed9a0d6043</originalsourceid><addsrcrecordid>eNp9kstu1DAUhiMEolXpC7BAltiwIMW32MkGqZpyqVSpG2BreZyTGVeJHexkpL5PH5STTplShLAXvn3nt8_xXxSvGT1jlOoPmTHaqJJyXlImdVXWz4pjzhkttWbs-WFOxVFxmvMNxSYVZ5V8WRwJJZRWlB0Xdxewgz6OA4TpPfHD2MMytZOPgdjQEtjZft4vY0csyciHsrW3xPU-eGd7Mm5tGqy7xbO08w6Ix1AyQZq8TbckQQcpITeBdVsfNmQb8-gn3GnntKzznDZQ8uWCaQtkdf3j8qJkDRnxATB496p40dk-w-nDeFJ8__zp2-preXX95XJ1flW6SrKpdJwpWdmm0qoVkitFJROar7nVle5Ex_naUsklXYsKurVlWui2qqFtLG0RFifFx73uOK8HaB0WAt9txuQHTMRE683Tk-C3ZhN3plEVVUqjwLsHgRR_zpAnM_jsoO9tgDhnw7Woas2rhiL69i_0Js4pYHqG11RzwVDvkdrYHowPXcR73SJqzrXUUjS0Vkid_YPCfl-9GKDzuP8kgO8DXIo54wcdcmTULPYye3sZtJe5t5epMejNn9U5hPw2EwJiD-Rx-VZIjyn9R_YX5P7aoQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2807231673</pqid></control><display><type>article</type><title>Development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the COVID-19 pandemic</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Cheng, C. ; Walsh, A. ; Jones, S. ; Matthews, S. ; Weerasooriya, D. ; Fernandes, R. J. ; McKenzie, C. A.</creator><creatorcontrib>Cheng, C. ; Walsh, A. ; Jones, S. ; Matthews, S. ; Weerasooriya, D. ; Fernandes, R. J. ; McKenzie, C. A.</creatorcontrib><description>Background
Seven-day clinical pharmacy services in the acute sector of the National Health Service are limited. There is a paucity of evidential patient benefit. This limits investment and infrastructure, despite United Kingdom wide calls.
Aim
To optimise medicines seven-days a week during surge-2 of the COVID-19 pandemic through implementation of a seven-day clinical pharmacy service. This paper describes service development, evaluation and sustainability.
Setting
A tertiary-referral teaching hospital, London, United Kingdom.
Development
The seven-day clinical pharmacy service was developed to critical care, acute and general medical patients. Clinical leads developed the service specification and defined priorities, targeting complex patients and transfer of care. Contributing staff were briefed and training materials developed.
Implementation
The service was implemented in January 2021 for 11 weeks. Multidisciplinary team communication brought challenges; strategies were employed to overcome these.
Evaluation
A prospective observational study was conducted in intervention wards over two weekends in February 2021. 1584 beds were occupied and 602 patients included. 346 interventions were reported and rated; 85.6% had high or moderate impact; 56.7% were time-critical.
The proportion of medicines reconciliation within 24-h of admission was analysed across the hospital between November 2020 and May 2021. During implementation, patients admitted Friday-Sunday were more likely to receive medicines reconciliation within 24-h (RR 1.41 (95% CI 1.34–1.47),
p
< 0.001). Rostered services were delivered sustainably in terms of shift-fill rate and medicines reconciliation outcome.
Conclusion
Seven-day clinical pharmacy services benefit patient outcome through early medicines reconciliation and intervention. Investment to permanently embed the service was sustained.</description><identifier>ISSN: 2210-7703</identifier><identifier>EISSN: 2210-7711</identifier><identifier>DOI: 10.1007/s11096-022-01475-8</identifier><identifier>PMID: 36367601</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Coronaviruses ; COVID-19 ; COVID-19 - epidemiology ; ESCP Best Practice ; Hospitals, Teaching ; Humans ; Internal Medicine ; Medication Reconciliation ; Medicine ; Medicine & Public Health ; Pandemics ; Patients ; Pharmacists ; Pharmacy ; Pharmacy Service, Hospital ; Reconciliation ; Referral and Consultation ; State Medicine ; Sustainable development ; Teaching hospitals ; Tertiary Care Centers</subject><ispartof>International journal of clinical pharmacy, 2023-04, Vol.45 (2), p.293-303</ispartof><rights>The Author(s) 2022</rights><rights>2022. The Author(s).</rights><rights>COPYRIGHT 2023 Springer</rights><rights>The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c541t-c21645a9576d34266041372b2a757f3f22ba04240b35efba1737d58ed9a0d6043</citedby><cites>FETCH-LOGICAL-c541t-c21645a9576d34266041372b2a757f3f22ba04240b35efba1737d58ed9a0d6043</cites><orcidid>0000-0003-1545-7612</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11096-022-01475-8$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11096-022-01475-8$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,315,782,786,887,27931,27932,41495,42564,51326</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36367601$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cheng, C.</creatorcontrib><creatorcontrib>Walsh, A.</creatorcontrib><creatorcontrib>Jones, S.</creatorcontrib><creatorcontrib>Matthews, S.</creatorcontrib><creatorcontrib>Weerasooriya, D.</creatorcontrib><creatorcontrib>Fernandes, R. J.</creatorcontrib><creatorcontrib>McKenzie, C. A.</creatorcontrib><title>Development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the COVID-19 pandemic</title><title>International journal of clinical pharmacy</title><addtitle>Int J Clin Pharm</addtitle><addtitle>Int J Clin Pharm</addtitle><description>Background
Seven-day clinical pharmacy services in the acute sector of the National Health Service are limited. There is a paucity of evidential patient benefit. This limits investment and infrastructure, despite United Kingdom wide calls.
Aim
To optimise medicines seven-days a week during surge-2 of the COVID-19 pandemic through implementation of a seven-day clinical pharmacy service. This paper describes service development, evaluation and sustainability.
Setting
A tertiary-referral teaching hospital, London, United Kingdom.
Development
The seven-day clinical pharmacy service was developed to critical care, acute and general medical patients. Clinical leads developed the service specification and defined priorities, targeting complex patients and transfer of care. Contributing staff were briefed and training materials developed.
Implementation
The service was implemented in January 2021 for 11 weeks. Multidisciplinary team communication brought challenges; strategies were employed to overcome these.
Evaluation
A prospective observational study was conducted in intervention wards over two weekends in February 2021. 1584 beds were occupied and 602 patients included. 346 interventions were reported and rated; 85.6% had high or moderate impact; 56.7% were time-critical.
The proportion of medicines reconciliation within 24-h of admission was analysed across the hospital between November 2020 and May 2021. During implementation, patients admitted Friday-Sunday were more likely to receive medicines reconciliation within 24-h (RR 1.41 (95% CI 1.34–1.47),
p
< 0.001). Rostered services were delivered sustainably in terms of shift-fill rate and medicines reconciliation outcome.
Conclusion
Seven-day clinical pharmacy services benefit patient outcome through early medicines reconciliation and intervention. Investment to permanently embed the service was sustained.</description><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - epidemiology</subject><subject>ESCP Best Practice</subject><subject>Hospitals, Teaching</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Medication Reconciliation</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Pandemics</subject><subject>Patients</subject><subject>Pharmacists</subject><subject>Pharmacy</subject><subject>Pharmacy Service, Hospital</subject><subject>Reconciliation</subject><subject>Referral and Consultation</subject><subject>State Medicine</subject><subject>Sustainable development</subject><subject>Teaching hospitals</subject><subject>Tertiary Care Centers</subject><issn>2210-7703</issn><issn>2210-7711</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kstu1DAUhiMEolXpC7BAltiwIMW32MkGqZpyqVSpG2BreZyTGVeJHexkpL5PH5STTplShLAXvn3nt8_xXxSvGT1jlOoPmTHaqJJyXlImdVXWz4pjzhkttWbs-WFOxVFxmvMNxSYVZ5V8WRwJJZRWlB0Xdxewgz6OA4TpPfHD2MMytZOPgdjQEtjZft4vY0csyciHsrW3xPU-eGd7Mm5tGqy7xbO08w6Ix1AyQZq8TbckQQcpITeBdVsfNmQb8-gn3GnntKzznDZQ8uWCaQtkdf3j8qJkDRnxATB496p40dk-w-nDeFJ8__zp2-preXX95XJ1flW6SrKpdJwpWdmm0qoVkitFJROar7nVle5Ex_naUsklXYsKurVlWui2qqFtLG0RFifFx73uOK8HaB0WAt9txuQHTMRE683Tk-C3ZhN3plEVVUqjwLsHgRR_zpAnM_jsoO9tgDhnw7Woas2rhiL69i_0Js4pYHqG11RzwVDvkdrYHowPXcR73SJqzrXUUjS0Vkid_YPCfl-9GKDzuP8kgO8DXIo54wcdcmTULPYye3sZtJe5t5epMejNn9U5hPw2EwJiD-Rx-VZIjyn9R_YX5P7aoQ</recordid><startdate>20230401</startdate><enddate>20230401</enddate><creator>Cheng, C.</creator><creator>Walsh, A.</creator><creator>Jones, S.</creator><creator>Matthews, S.</creator><creator>Weerasooriya, D.</creator><creator>Fernandes, R. J.</creator><creator>McKenzie, C. A.</creator><general>Springer International Publishing</general><general>Springer</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1545-7612</orcidid></search><sort><creationdate>20230401</creationdate><title>Development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the COVID-19 pandemic</title><author>Cheng, C. ; Walsh, A. ; Jones, S. ; Matthews, S. ; Weerasooriya, D. ; Fernandes, R. J. ; McKenzie, C. A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c541t-c21645a9576d34266041372b2a757f3f22ba04240b35efba1737d58ed9a0d6043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - epidemiology</topic><topic>ESCP Best Practice</topic><topic>Hospitals, Teaching</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Medication Reconciliation</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Pandemics</topic><topic>Patients</topic><topic>Pharmacists</topic><topic>Pharmacy</topic><topic>Pharmacy Service, Hospital</topic><topic>Reconciliation</topic><topic>Referral and Consultation</topic><topic>State Medicine</topic><topic>Sustainable development</topic><topic>Teaching hospitals</topic><topic>Tertiary Care Centers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cheng, C.</creatorcontrib><creatorcontrib>Walsh, A.</creatorcontrib><creatorcontrib>Jones, S.</creatorcontrib><creatorcontrib>Matthews, S.</creatorcontrib><creatorcontrib>Weerasooriya, D.</creatorcontrib><creatorcontrib>Fernandes, R. J.</creatorcontrib><creatorcontrib>McKenzie, C. A.</creatorcontrib><collection>Springer Nature OA/Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of clinical pharmacy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cheng, C.</au><au>Walsh, A.</au><au>Jones, S.</au><au>Matthews, S.</au><au>Weerasooriya, D.</au><au>Fernandes, R. J.</au><au>McKenzie, C. A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the COVID-19 pandemic</atitle><jtitle>International journal of clinical pharmacy</jtitle><stitle>Int J Clin Pharm</stitle><addtitle>Int J Clin Pharm</addtitle><date>2023-04-01</date><risdate>2023</risdate><volume>45</volume><issue>2</issue><spage>293</spage><epage>303</epage><pages>293-303</pages><issn>2210-7703</issn><eissn>2210-7711</eissn><abstract>Background
Seven-day clinical pharmacy services in the acute sector of the National Health Service are limited. There is a paucity of evidential patient benefit. This limits investment and infrastructure, despite United Kingdom wide calls.
Aim
To optimise medicines seven-days a week during surge-2 of the COVID-19 pandemic through implementation of a seven-day clinical pharmacy service. This paper describes service development, evaluation and sustainability.
Setting
A tertiary-referral teaching hospital, London, United Kingdom.
Development
The seven-day clinical pharmacy service was developed to critical care, acute and general medical patients. Clinical leads developed the service specification and defined priorities, targeting complex patients and transfer of care. Contributing staff were briefed and training materials developed.
Implementation
The service was implemented in January 2021 for 11 weeks. Multidisciplinary team communication brought challenges; strategies were employed to overcome these.
Evaluation
A prospective observational study was conducted in intervention wards over two weekends in February 2021. 1584 beds were occupied and 602 patients included. 346 interventions were reported and rated; 85.6% had high or moderate impact; 56.7% were time-critical.
The proportion of medicines reconciliation within 24-h of admission was analysed across the hospital between November 2020 and May 2021. During implementation, patients admitted Friday-Sunday were more likely to receive medicines reconciliation within 24-h (RR 1.41 (95% CI 1.34–1.47),
p
< 0.001). Rostered services were delivered sustainably in terms of shift-fill rate and medicines reconciliation outcome.
Conclusion
Seven-day clinical pharmacy services benefit patient outcome through early medicines reconciliation and intervention. Investment to permanently embed the service was sustained.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>36367601</pmid><doi>10.1007/s11096-022-01475-8</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0003-1545-7612</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2210-7703 |
| ispartof | International journal of clinical pharmacy, 2023-04, Vol.45 (2), p.293-303 |
| issn | 2210-7703 2210-7711 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9650667 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Coronaviruses COVID-19 COVID-19 - epidemiology ESCP Best Practice Hospitals, Teaching Humans Internal Medicine Medication Reconciliation Medicine Medicine & Public Health Pandemics Patients Pharmacists Pharmacy Pharmacy Service, Hospital Reconciliation Referral and Consultation State Medicine Sustainable development Teaching hospitals Tertiary Care Centers |
| title | Development, implementation and evaluation of a seven-day clinical pharmacy service in a tertiary referral teaching hospital during surge-2 of the COVID-19 pandemic |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T05%3A25%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development,%20implementation%20and%20evaluation%20of%20a%20seven-day%20clinical%20pharmacy%20service%20in%20a%20tertiary%20referral%20teaching%20hospital%20during%20surge-2%20of%20the%20COVID-19%20pandemic&rft.jtitle=International%20journal%20of%20clinical%20pharmacy&rft.au=Cheng,%20C.&rft.date=2023-04-01&rft.volume=45&rft.issue=2&rft.spage=293&rft.epage=303&rft.pages=293-303&rft.issn=2210-7703&rft.eissn=2210-7711&rft_id=info:doi/10.1007/s11096-022-01475-8&rft_dat=%3Cgale_pubme%3EA747439086%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2807231673&rft_id=info:pmid/36367601&rft_galeid=A747439086&rfr_iscdi=true |